• Arbi or Taro Root: More than Just a Starchy Vegetable

    Often overlooked in modern kitchens, the humble arbi, or taro root, is far more than just a starchy vegetable. While it is indeed rich in carbohydrates, this characteristic alone does a disservice to its remarkable nutritional profile, its deep-rooted history in South Asian agriculture, and its longstanding place in traditional medicine. A common misconception, fueled by a similarity in sound, suggests that the name “arbi” has something to do with the Arabian Peninsula. This is entirely incorrect. The word “arbi”, also spelled arvi, is not derived from “Arab” or any Semitic root. Instead, its origin lies in the ancient languages of the Indian subcontinent. Linguists trace it back to Ālukī or Kachchū, which then evolved into Prakrit forms like Alubbī or Arubbī. Some scholars also point to a possible Dravidian source, such as the Tamil word avi or the Kannada arve, referring to certain tubers. Regardless of the precise path, what is clear is that the name “arbi” is native to North Indian and Pakistani languages, and has no geographical or linguistic connection to Arabia. The vegetable itself has been cultivated in South Asia for millennia, with archaeological evidence and ancient texts confirming its presence thousands of years ago, long before any significant contact with the Arabian Peninsula.

    This long history is reflected in the sheer variety of names for arbi across the subcontinent. In Bengali, it is called kochu; in Gujarati, alwi; in Marathi, alu. Down south, Tamil speakers know it as cheppankizhangu, Telugu speakers as chamadumpa, Kannada speakers as kesave or samagadde, and Malayalam speakers as chembu. In Odia, it is saru, and in Nepali, pindalu. This linguistic diversity is a testament to how deeply arbi is woven into the culinary and cultural fabric of South Asia, from Kashmir to Kerala, often growing wild in damp, marshy areas near riverbanks.

    Beyond its linguistic and cultural roots, arbi is nutritionally dense. A typical serving contains a significant amount of energy-providing complex carbohydrates. Especially when the vegetable is cooled after cooking, these starches convert into resistant starch, which acts more like fiber, slowing digestion, promoting gut health, and preventing sharp spikes in blood sugar. Furthermore, arbi offers a moderate amount of protein for a root vegetable, around two grams per hundred-gram serving. While this is not high by legume or meat standards, it is a meaningful contribution in plant-based diets and, when paired with lentils, beans, or dairy, helps form a more complete amino acid profile. Beyond these macronutrients, arbi shines as a source of potassium for blood pressure regulation, magnesium for nerve function, vitamin B6 for metabolism, and significant amounts of vitamin E and manganese—antioxidants that protect cells from damage. It is naturally gluten-free, low in fat, and contains no cholesterol, making it an excellent alternative to refined grains for those with celiac disease or insulin resistance.

    The wisdom of traditional medicine systems further elevates arbi from a simple food to a functional therapeutic agent. In Ayurveda, arbi is valued for its numerous health benefits, though with a clear caveat: it is known to increase Vata dosha, which can lead to gas or joint discomfort if not prepared correctly. This is why traditional recipes often pair arbi with digestive spices like carom seeds (ajwain) or ginger. Ayurvedic texts document using the juice of the arbi corm massaged onto the scalp to combat hair fall, and mixing it with buttermilk to relieve headaches. A few drops of leaf juice are traditionally placed in the ear for pain or discharge, while a paste of the leaves and stems with salt is applied topically to reduce inflammation. For internal ailments, a decoction of the corm is used for constipation, roasted arbi mashed into a bharta is eaten for body weakness, and the juice of leaves mixed with cinnamon and cardamom is prescribed for low appetite. Even high blood pressure and diarrhea are said to be managed with specific preparations of this versatile root.

    Similarly, the Unani system of medicine, which focuses on balancing the body’s humors, embraces arbi within its dietary therapy known as Ilaj bil Ghiza. This approach considers food the simplest and most natural way to restore health, believing that nutrient-dense ingredients like arbi strengthen the body’s innate defense system, or tabiyat. While Unani texts classify foods by their temperament, arbi’s rich fiber and mineral content would be recommended to correct imbalances, particularly those affecting digestion and blood quality. Despite these immense benefits, both traditional systems advise caution. Because arbi can aggravate Vata, those with knee pain or inflammatory conditions should consume it mindfully, and in Unani philosophy, even a beneficial food can cause harm if eaten in excess or in a way that contradicts one’s unique constitution. In essence, when prepared thoughtfully and eaten in appropriate portions, arbi is not merely a carb-rich vegetable but a time-honored, nutrient-dense food that bridges the gap between sustenance, culture, and medicine.

  • Ashwagandha: Banned in Denmark – Leaves Banned in India

    Ashwagandha, a staple in Ayurvedic medicine, is widely used today for stress relief, sleep support, and general vitality. Its roots are valued as an adaptogen that helps the body cope with physical and mental strain, while its leaves have historically been used in traditional preparations as well. In recent years, however, both international and Indian regulators have raised safety concerns, particularly around the use of ashwagandha leaves and their extracts in food and health supplements. As of April 2026, the Food Safety and Standards Authority of India has formally banned the use of ashwagandha leaves and their extracts in health supplements and food products, while still permitting root‑based preparations. Around the same time, Denmark banned ashwagandha‑containing products as food supplements in 2023, citing potential thyroid and reproductive‑system effects. These regulatory actions reflect a growing consensus that certain parts of the plant, especially the leaves, carry a higher risk profile than the roots.

    The core of this concern lies in the chemical composition of ashwagandha’s different plant parts. The leaves contain notably higher levels of reactive withanolides, particularly withaferin‑A, which is a more cytotoxic and potentially hepatotoxic compound. Studies from phytochemical and toxicology research show that leaves and stems often accumulate several‑fold more withaferin‑A than roots, while roots contain a different mix of withanolides such as withanolide A and withanone, which are generally associated with more favourable neuroprotective and adaptogenic effects. This does not mean the roots are inert; they still contain some of these reactive withanolides, albeit at lower concentrations and in a more balanced profile. The practical implication is that leaf‑based products are likely to expose consumers to a higher load of potentially toxic compounds, which is why regulators have moved to restrict or ban their use in food and supplements.

    Given this background, the question naturally arises whether ashwagandha root preparations themselves should be treated with caution. The evidence suggests that they should be. While root extracts are generally considered safer than leaf‑based ones, they are not entirely risk‑free. Modern clinical trials and safety reviews indicate that standard doses of root extract—typically in the range of about 300–600 mg per day, standardized to around 5–10% withanolides for a few weeks to a few months—can be well tolerated in many healthy adults. However, data on long‑term use are limited, and there are well‑documented case reports of liver injury linked to ashwagandha products, even when only the roots were used. These cases underscore that “natural” does not automatically mean “harmless,” and that dose, duration, and individual susceptibility all matter.

    Liver‑related adverse effects are one of the most serious risks associated with ashwagandha. The signs of liver damage are similar to those seen with other drug‑induced liver injuries and typically appear weeks to a few months after starting the supplement. Early warning symptoms include persistent fatigue, loss of appetite, nausea, and a feeling of being generally unwell. More specific signs are jaundice—yellowing of the skin or the whites of the eyes—often accompanied by dark‑coloured urine and sometimes pale or clay‑coloured stools. Pain or a feeling of heaviness in the upper right abdomen, just under the ribs, can also occur. In documented cases, blood tests reveal elevated liver enzymes (ALT, AST), increased bile‑duct markers (ALP, GGT), and raised bilirubin, reflecting a cholestatic or mixed pattern of liver injury. Importantly, these changes often improve after stopping ashwagandha, reinforcing the need for prompt recognition and discontinuation.

    Because of these risks, anyone using ashwagandha root supplements should take a cautious, informed approach. It is wise to avoid very high doses or prolonged continuous use without medical supervision, especially if there is any pre‑existing liver condition, fatty liver, or ongoing treatment with other medications that can affect the liver. People with pregnancy, breastfeeding, autoimmune disorders, or thyroid disease should also be particularly cautious, since ashwagandha can influence hormone pathways and interacting with thyroid medications. Before starting or continuing any ashwagandha regimen, discussing the dose and formulation with a healthcare provider and, if possible, checking baseline liver‑function tests are prudent steps. If symptoms such as jaundice, dark urine, persistent nausea, or right‑upper‑abdominal pain appear, ashwagandha should be stopped immediately and medical evaluation sought. In this regulatory and safety context, the plant’s traditional benefits need to be weighed against its potential risks, with an emphasis on using root‑based preparations in moderate, time‑limited doses rather than as indefinite, high‑intensity supplements.